Johnson & Johnson, United States
Disclosure information not submitted.
5C-02 - Quantitative Bias Analysis to Assess Impact of Outcome Misclassification in a Claims-based COVID-19 Vaccine Safety Study in the US
Tuesday, August 26, 20258:45 AM - 9:00 AM ET
5C-04 - An Observational Postauthorization Safety Study to Assess Adverse Events of Special Interest in Recipients of Ad26.COV2.S in the United States
Tuesday, August 26, 20259:15 AM - 9:30 AM ET
